USPTO serial 79336509
PALYNOX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 23, 2024
- Examiner
- HOLLAND, JAMI ELENA
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PALYNOX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700DENVER, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; phytopharmaceutical preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; dietetic and homeopathic products for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; medical preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; veterinary preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; food and dietary supplements for humans and animals; dietetic food adapted for medical or veterinary use; food supplements consisting of vitamins; food supplements for pharmaceutical use; food supplements for animals; vitamin and mineral food supplements; pharmaceutical for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression sold on prescription or over the counter; veterinary preparations for pets for the treatment of allergies sold on prescription or over the counter; food supplements for pharmaceutical and veterinary use; natural food supplements for allergy treatment; chemical preparations for medical use, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; chemical preparations for pharmaceutical use, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; medicinal preparations, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; plant preparations for medical use, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; [ the above-mentioned goods are not intented to be manufactured, commercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy ] * the aforesaid goods are not intended to be manufactured, marketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy * | ACTIVE | — |
| 042 | Scientific and technological services, namely, research in the fields of chemistry, biology and pharmacy; industrial research in the field of pharmaceutical preparations and food supplements for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; industrial design services; quality control of goods and services in the field of pharmaceutical preparations; pharmaceutical research and development services; pharmaceutical research services; laboratory research services in the field of pharmaceuticals; [ the above-mentioned services are not intented to be manufactured, commercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy ] * the aforesaid services are not intended to be manufactured, marketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy * | ACTIVE | — |
| 044 | Health care for human beings, including dietetic and medical services; veterinary services; medical examination services; provision of information relating to dietary and nutritional supplements; consultancy in the pharmaceutical and healthcare services field; advice and information relating to the aforesaid services; advisory services relating to health care; hygienic and beauty care; [ the above-mentioned services are not intented to be manufactured, commercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy ] * the aforesaid services are not intended to be manufactured, marketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy * | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Monsieur Christian Strunden
- Other trademarks owned by Monsieur Christian Strunden
- Other trademarks owned by Monsieur Christian Strunden
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PALYNOX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 23, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Sep 10, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 6, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 28, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jan 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 8, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 8, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 6, 2025 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jan 6, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jan 6, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 15, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 15, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 23, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 14, 2024 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jun 14, 2024 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 14, 2024 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Apr 28, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 9, 2024 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Feb 4, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 16, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 1, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 11, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jul 4, 2023 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Jul 4, 2023 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Apr 5, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 15, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 15, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 31, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2022 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 5, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 4, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 2, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 1, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |